Moxizia-LB 625 Tablet

About Moxizia-LB 625 Tablet

Moxizia-LB 625 is a combination tablet containing Amoxycillin 500 mg, Clavulanic Acid 125 mg, and Lactic Acid Bacillus 60 million spores. It is prescribed to treat a wide range of bacterial infections where standard antibiotics may not be effective, as the Clavulanic Acid helps overcome antibiotic resistance by shielding Amoxycillin from bacterial enzymes.

The addition of Lactic Acid Bacillus in Moxizia-LB 625 is a thoughtful touch — it helps replenish the good bacteria in your gut during antibiotic therapy, reducing the chances of stomach upset or antibiotic-associated diarrhoea, making the treatment course more comfortable.

Uses of Moxizia-LB 625 Tablet

This medicine is commonly used for:

• Respiratory tract infections like bronchitis and pneumonia
• Ear, nose, and throat infections including sinusitis and tonsillitis
• Urinary tract infections
• Skin and soft tissue infections
• Dental infections and abscesses

Indications

Amoxycillin-Clavulanic Acid is indicated for the treatment of infections caused by beta-lactamase-producing organisms including Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Escherichia coli. Clinical indications include acute bacterial sinusitis, community-acquired pneumonia, acute otitis media, urinary tract infections, skin and soft-tissue infections, and dental infections. Lactic Acid Bacillus is incorporated as a probiotic adjunct to mitigate antibiotic-associated gastrointestinal dysbiosis.

How Moxizia-LB 625 Tablet Works

Amoxycillin in Moxizia-LB 625 kills bacteria by breaking down their protective outer walls, stopping them from surviving. Clavulanic Acid acts as a shield for Amoxycillin, blocking the enzymes that certain resistant bacteria use to destroy the antibiotic. The probiotic Lactic Acid Bacillus helps maintain a healthy balance of good bacteria in your gut throughout the treatment.

Mechanism of Action

Amoxycillin is a broad-spectrum aminopenicillin that inhibits bacterial cell-wall synthesis by binding to penicillin-binding proteins (PBPs), preventing cross-linking of peptidoglycan strands, leading to cell lysis. Clavulanic Acid is an irreversible suicide inhibitor of beta-lactamase enzymes (classes A and C), thereby restoring Amoxycillin's activity against resistant organisms. Lactic Acid Bacillus colonises the gastrointestinal tract, competitively excluding pathogenic flora and restoring eubiosis by producing lactic acid, bacteriocins, and supporting mucosal IgA secretion.

Key Benefits

• Broad-spectrum coverage including resistant bacteria that defeat plain Amoxycillin
• Probiotic component helps prevent antibiotic-associated diarrhoea
• Well-established safety profile suitable for adults and children
• Effective against a wide range of common infection sites

When & How to Take

Moxizia-LB 625 is generally taken with food to reduce the chances of stomach upset, for the duration your doctor prescribes. Always complete the full course even if you feel better early, as directed by your doctor. Never alter the dose or frequency without medical advice.

Always follow the dosage and schedule advised by your doctor — this is general guidance only.

Possible Side Effects

Common side effects may include nausea, vomiting, diarrhoea, and stomach discomfort — the probiotic in this tablet helps reduce these. Some people may notice a skin rash or headache. Rarely, a severe allergic reaction may occur. Tell your doctor if any side effect is severe or persistent.

Precautions & Safety

• Inform your doctor of any known allergy to penicillin or cephalosporin antibiotics
• Complete the full prescribed course to prevent antibiotic resistance
• Let your doctor know about any kidney or liver problems before starting
• Avoid self-medicating or sharing this antibiotic with others
• Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding

Myths vs Facts

Frequently Asked Questions